The Effect of Gastric Bypass Surgery on the Glucose Metabolism Seen in Patients With Type 2 Diabetes

Sponsor
Hvidovre University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00810823
Collaborator
(none)
25
1
26.9
0.9

Study Details

Study Description

Brief Summary

Gastric bypass surgery has in many studies shown total remission of type 2 diabetes as early as 1 - 2 days after surgery and this is before any real weight loss has occurred. This suggest that the remission of the diabetes is due to the direct effect of the operation more that the secondary effect of the weight loss. The reason for the major effect on the glucose metabolism after gastric bypass surgery is still unaccounted for.

This PhD. project will try to unveil some of the mechanisms that could explain the effect of gastric bypass surgery on the glucose metabolism seen in patients with type 2 diabetes.

The hypothesis of the study is that a factor "X" will course the remission of the diabetes. This factor "X" is related to the anatomic changes of the gastro intestinal tract, by eliminating the foods passage through the distal part of the ventricle and the duodenum, in combination with the Roux- en-Y sling.

The PhD. project will consist of clinical trails on patients that will undergo gastric bypass surgery. The studies will take place before and within the 1. week after surgery. The investigators will measure different hormones and adipokines in fast and the postprandial state. To discover possible new proteins the investigators will run proteomic on some samples. All the results will be compared to the same parameter on patients undergoing gastric banding, where the anatomy of the intestine hasn't been changed.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    25 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Effect of Gastric Bypass Surgery on the Glucose Metabolism Seen in Patients With Type 2 Diabetes
    Study Start Date :
    Jan 1, 2009
    Actual Primary Completion Date :
    Apr 1, 2011
    Actual Study Completion Date :
    Apr 1, 2011

    Arms and Interventions

    Arm Intervention/Treatment
    1:Gastric bypass/diabetes

    Patients undergoing gastric bypass surgery, and who are diagnosed with type 2 diabetes.

    2:Gastric bypass/not Diabetic

    Patients undergoing gastric bypass surgery, not diagnosed with diabetes.

    Outcome Measures

    Primary Outcome Measures

    1. What is the factor "X" that cause the remission of type 2 diabetes after gastric bypass [about 3 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • The inclusion criteria in Denmark for undergoing gastric bypass and see the above study and cohort description.

    • Well treated hypertension < 145/85. HbA1C <8,5 % and c-peptid> 700pmol/l

    Exclusion Criteria:
    • In treatment with antidepressive, DPP-4 inhibitors and intreatment for thyroid problems.

    • Patients treated with insulin.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hvidovre Hospital Hvidovre Denmark 2650

    Sponsors and Collaborators

    • Hvidovre University Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00810823
    Other Study ID Numbers:
    • H-A-2008-080
    First Posted:
    Dec 18, 2008
    Last Update Posted:
    Jul 6, 2011
    Last Verified:
    Dec 1, 2008

    Study Results

    No Results Posted as of Jul 6, 2011